wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38893074-9065FDC6-D40E-4302-A889-CE2483C28D58
Q38893074-9065FDC6-D40E-4302-A889-CE2483C28D58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38893074-9065FDC6-D40E-4302-A889-CE2483C28D58
Biology and Management of Patients With Triple-Negative Breast Cancer.
P2860
Q38893074-9065FDC6-D40E-4302-A889-CE2483C28D58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38893074-9065FDC6-D40E-4302-A889-CE2483C28D58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d39be1d3c6c53eee7b7e58f8c9dc5a0a3d40bf2b
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105